Immediate Impact
1 from Science/Nature 74 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of Joseph Burke being referenced
Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
2012 Standout
Continuation of EGFR/ALK inhibition after local therapy of oligoprogressive disease in EGFR mutant (Mt) and ALK+ non-small cell lung cancer (NSCLC).
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Joseph Burke | 36 | 481 | 387 | 97 | 7 | 551 | |
| KEIICHI SUEMASU | 17 | 498 | 221 | 87 | 8 | 638 | |
| Isabelle Gauthier | 20 | 295 | 274 | 212 | 11 | 569 | |
| Andrew K. Chung | 24 | 274 | 198 | 84 | 9 | 495 | |
| Terence Rugg | 8 | 257 | 290 | 121 | 5 | 469 | |
| Yenting Ngai | 35 | 376 | 268 | 76 | 17 | 544 | |
| Y. Nakanishi | 5 | 435 | 230 | 109 | 7 | 608 | |
| Sharma P. Riaz | 15 | 301 | 312 | 60 | 9 | 509 | |
| Nathalie Syz | 5 | 281 | 276 | 59 | 5 | 476 | |
| Maria Cristina Bruna | 9 | 254 | 234 | 32 | 13 | 471 | |
| Jean-François Caubet | 21 | 247 | 197 | 113 | 8 | 460 |
All Works
Login with ORCID to disown or claim papers
Loading papers...